- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Discussing the Continuing Decline in Overall Cancer Mortality in the United States
In this podcast, we speak with Rebecca Siegel, MPH, strategic director of surveillance information services in the Intramural Research Department at the American Cancer Society, and the lead author of the annual Cancer Statistics report that estimates the number of new cancer cases and deaths in the United States each year.
For the 25th consecutive year, overall cancer mortality rates in the United States have dropped. However, while many cancers have experienced declining rates of incidence and mortality, others have not. In addition, racial and socioeconomic factors continue to play a role in inequalities among cancer incidence and mortality rates.
In this podcast, we speak with Rebecca Siegel, MPH, strategic director of surveillance information services in the Intramural Research Department at the American Cancer Society, and the lead author of the annual Cancer Statistics report that estimates the number of new cancer cases and deaths in the United States each year.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
Read more on cancer incidence and mortality:
Cancer Mortality Rate Drops for the 25th Consecutive Year, but Socioeconomic Gap Widens
Cancer Surpasses CVD as Leading Cause of Death in High-Income Counties
5-Year Survival Rates for Patients With Cancer Worldwide
After Two Decades of Decline, Prostate Cancer Mortality Rates Have Stabilized
As Cancer Incidence Changes, So Do Screening Recommendations
FDA Approves Danziten for Chronic Myeloid Leukemia Without Mealtime Restrictions
November 14th 2024The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase inhibitor for chronic myeloid leukemia that can be taken without mealtime restrictions.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
